Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Abstract

Standard approaches to modelling outcomes commonly include a range of predictors such as age, sex and co-morbidities. However, there is growing evidence that quality-of-life (QoL) is also an important predictor of
mortality.

Whilst the effects of standard risk factors have been adequately captured to describe mortality in most models, the omission of QoL indicates the assumption of full independence between QoL and life expectancy (LE). This omission could give rise to systematic bias when measuring quality-adjusted life years (QALYs).

Using data from a registry cohort of patients undergoing total knee replacement (TKR), potential correlations between baseline utility, change in utility and survival are explored using parametric survival models. Outcomes such as LE, QALYs, and incremental cost-effectiveness ratios (ICERs) were calculated and compared.

Forthcoming events

Health and economic impacts of Lassa vaccination campaigns in West Africa

Monday, 20 January 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar room

Host-parasite interactions

Monday, 27 January 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

Marburg vaccine trial

Monday, 03 February 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

Tuberculosis vaccine R&D and human challenge models

Monday, 10 February 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

Shingles vaccine and dementia, and other links between infectious diseases and brain health

Monday, 24 February 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

Using the adenoviral vectored vaccine platform for bacterial infections

Monday, 03 March 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms